help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McDowell, S. A.
Right arrow Articles by Waltz, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McDowell, S. A.
Right arrow Articles by Waltz, S. E.
Am. J. Respir. Cell Mol. Biol., Volume 26, Number 1, January 2002 99-104

The Role of the Receptor Tyrosine Kinase Ron in Nickel-Induced Acute Lung Injury

Susan A. McDowell, Ali Mallakin, Cindy J. Bachurski, Kenya Toney-Earley, Daniel R. Prows, Theresa Bruno, Klaus H. Kaestner, David P. Witte, Hector Melin-Aldana, Sandra J. F. Degen, George D. Leikauf, and Susan E. Waltz

Departments of Environmental Health, Molecular and Cellular Physiology, and Pulmonary and Critical Care Medicine, University of Cincinnati, Cincinnati; Divisions of Developmental Biology, Pulmonary Biology, Pathology, and Gastroenterology, Children's Hospital Research Foundation, Cincinnati, Ohio; and Department of Genetics, University of Pennsylvania Medical School, Philadelphia, Pennsylvania


    Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Acute lung injury (ALI), a severe respiratory syndrome, develops in response to numerous insults and responds poorly to therapeutic intervention. Recently, cDNA microarray analyses were performed that indicated several pathogenic responses during nickel-induced ALI, including marked macrophage activation. Macrophage activation is mediated, in part, via the receptor tyrosine kinase Ron. To address the role of Ron in ALI, the response of mice deficient in the cytoplasmic domain of Ron (Ron tk-/-) were assessed in response to nickel exposure. Ron tk-/- mice succumb to nickel-induced ALI earlier, express larger, early increases in interleukin-6, monocyte chemoattractant protein-1, and macrophage inflammatory protein-2, display greater serum nitrite levels, and exhibit earlier onset of pulmonary pathology and augmented pulmonary tyrosine nitrosylation. Increases in cytokine expression and cellular nitration can lead to tissue damage and are consistent with the differences between genotypes in the early onset of pathology and mortality in Ron tk-/- mice. These analyses indicate a role for the tyrosine kinase receptor Ron in ALI.


    Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Although initially described over 30 years ago, mortality from acute lung injury (ALI) remains high (35-50%) with an estimated 150,000 cases annually. The principal clinical manifestations of the syndrome include pulmonary edema, cellular infiltration, and airway collapse with hypoxia and multiple organ failure commonly leading to death. The pathogenesis of ALI is complex and typically involves epithelial and macrophage activation, enhanced proteolysis, increased expression of inflammatory mediators, and generation of reactive oxygen and nitrogen species (1, 2). However, questions remain regarding the factors regulating the initiation and progression of this complex response.

Exposure of mice to nickel models the initiation and progression of ALI with the development of pulmonary and perivascular edema, epithelial damage, and cellular infiltration (3, 4). Analysis from cDNA microarrays revealed temporal expression patterns of genes during the progression of nickel-induced ALI consistent with increased macrophage activation, excess nitric oxide (NO) production, and enhanced proteolysis (5).

Many of the responses that were noted with the cDNA microarray analysis, including marked macrophage activation, suggested that receptor tyrosine kinases may be important in the regulation of this complex syndrome. To begin to examine these proteins, we initially focused on the tyrosine kinase domain of Ron. Binding of the ligand hepatocyte growth factor-like protein/macrophage stimulating protein (HGFL/MSP) initiates phosphorylation of specific tyrosine residues within the intracellular catalytic domain of Ron (6). With phosphorylation, docking sites are created for interaction with intracellular signaling molecules, including phosphatidylinositol-3 (PI-3) kinase (7), that modulate several cellular responses, including inhibition of NO synthesis by peritoneal macrophage (8). Because overproduction of NO is damaging to tissue (9), we postulated that through inhibition of NO synthesis, Ron may be important in nickel-induced ALI. To determine the significance of Ron during ALI, mice deficient in the tyrosine kinase domain of this receptor were used. Mice lacking this domain are viable (10), but demonstrate susceptibility to endotoxin with increased lethality in vivo and the overproduction of NO metabolites from isolated macrophage in vitro. In the present study, mice deficient in the tyrosine kinase domain of Ron were assessed for survival, pulmonary cytokine expression, NO synthesis, pulmonary tyrosine nitration, and tissue damage in response to nickel-induced ALI.

    Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Experimental Design

We proposed that disruption of the Ron signaling pathway would increase sensitivity to nickel-induced ALI. Therefore, survival time of Ron tk-/- mice was monitored relative to Ron tk+/+ mice during continuous exposure to nickel. Disruption of the Ron signaling pathway could disrupt regulation of cytokine expression, therefore, we next examined expression of interleukin (IL)-6, macrophage inflammatory protein (MIP)-2, monocyte chemotactic protein (MCP)-1, tumor necrosis factor (TNF)-alpha , macrophage migration inhibitory factor (MIF), IL-1beta , regulated upon activation, normal T cells expressed and secreted (RANTES), transforming growth factor (TGF)-alpha , inducible NO synthase (iNOS), IL-10, IL-12, granulocyte macrophage-colony stimulating factor (GM-CSF), and interferon (IFN)-gamma . Because Ron inhibits NO synthesis, serum nitrite, a stable NO metabolite, was measured and tyrosine nitration was examined using immunohistochemistry. Lung pathology was evaluated by histology and by lung wet-to-dry weight ratios before exposure and at death.

Mice and Exposure

Mice (6-10 wk; sex matched) containing a deletion of the tyrosine kinase domain of the mouse Ron gene were generated as described (10). Briefly, loxP sites were incorporated into introns flanking exons 13 and 18 of the Ron gene by homologous recombination into embryonic stem cells, creating a floxed allele (11). Mice homozygous for the floxed Ron allele were generated by standard techniques. To delete sequences encompassed by the loxP sites, mice homozygous for the floxed Ron allele were mated to mice heterozygous for Cre recombinase driven by the endogenous hepatocyte nuclear factor 3alpha gene sequence. Mice heterozygous for both the floxed Ron allele and Cre recombinase were backcrossed to mice homozygous for the floxed Ron allele. In offspring from this cross, Cre mediated deletion of exons 13 through 18 was verified by Southern, PCR, and Western analyses. This deletion occurred at 100% efficiency before embryonic Day 9.0 due to early systemic Cre expression. The Ron tyrosine kinase deficient mice express a truncated form of Ron, verified by Western blot analysis, which, when translated, produces a protein comprised of the entire extracellular and transmembrane domains and 5 amino acids of the cytoplasmic domain (10). For this study, control mice are designated as Ron tk+/+ and tyrosine kinase deficient mice are designated as Ron tk-/-. The Ron tk-/- mice and Ron tk+/+ mice used in this study were generated from crosses of hybrid mice (admixture of CD-1, Swiss Black, and 129). The genetic contribution from this admixture could contribute to the phenotype of the Ron tk-/- mice.

Mice were exposed to aerosolized NiSO4 (115 ± 7 µg/m3) and characterized as previously described (0.2 mm mass median aerodynamic diameter, 1.85 geometric standard deviation) (4) and survival monitored.

Pulmonary Cytokine Analysis

To assess lung cytokine transcript levels, mice (n = 3/time) were removed from nickel exposure, anaesthetized, exsanguinated, and the lobes of lung removed by incision at the major bronchi and immediately frozen in liquid nitrogen. Total RNA was isolated from homogenized lung (TRIZOL; Life Technologies, Gaithersburg, MD; Tissumizer, Tekmar-Dohrmann, Cincinnati, OH) and RNase protection assays were performed by modifying protocols from RiboQuant (PharMingen, San Diego, CA) and RPA III (Ambion, Austin, TX) (12). Template-sets (PharMingen) contained the following murine cDNA sequences: IL-6, MIP-2, MCP-1, TNF-alpha , MIF, IL-1beta , RANTES, TGF-alpha , iNOS, IL-10, IL-12, GM-CSF, IFN-gamma , and ribosomal protein L32. Antisense, radiolabeled RNA probes were generated from each template-set, 1 µL of template-set was incubated (37°C, 1 h) with 40 U RNasin, 0.14 mM each GTP/CTP/ATP, 0.003 mM UTP, 10 mM dithiothreitol, 1× Transcription Buffer (PharMingen), 0.1 mCi alpha -32P-uridine 5'-triphosphate (NEN, Boston, MA), and 20 U T7 RNA polymerase. The reaction was terminated by incubation with 2 U RNase-free DNase (37°C, 30 min). Following addition of 2 µg tRNA and 4 µL of 5× stop buffer (5× stop: 1 M ethylenediaminetetraacetic acid [EDTA], 10% Ficoll, 0.1% bromophenol blue), the radiolabeled probes were column purified (Roche, Indianapolis, IN). Total RNA (10 µg) was denatured (95°C, 5 min) and hybridized with 32P-labeled probe diluted to 200,000 cpm/µl (56°C, 16 h) in 16 µL deionized formamide (SigmaUltra) and 0.4 M NaCl, 2.0 mM EDTA, 0.04 M PIPES, pH 6.6. Following hybridization, single-stranded, unprotected RNA was digested using 3.8 U RNase A/152 U RNase T1/µl RNase Digestion III Buffer (Ambion) (37°C, 1 h). Protected fragments were precipitated using 225 µL RNase Inactivation/Precipitation III Solution (Ambion) and 100 µL 100% ethanol, resuspended in 95% formamide, 0.025% xylene cyanol and bromophenol blue, 18 mM EDTA, 0.025% sodium dodecyl sulfate, separated by denaturing electrophoresis (6% polyacrylamide gel containing 8 M urea), and quantified by PhosphorImager analysis (ImageQuant; Molecular Dynamics PhosphorImager, Sunnyvale, CA). The level of expression of each cytokine was normalized to the intensity of the L32 band.

Serum Nitrite Analyses

To assess serum nitrite levels, mice (n=4/time) were removed from exposure and anesthetized (3.3 mg ketamine; 0.165 mg xylazine; Phoenix, St.Joseph, MO; 0.085 mg acepromazine; Boehringer Ingelheim, Ingelheim, Germany). Blood was collected via the inferior vena cava, allowed to coagulate (30 min, RT), serum separated, and nitrite measured as previously described (13).

Pathology

To assess lung pathology, mice were anesthetized (5 mg Nembutal, Abbott, intraperitoneal), exsanguinated (by severing the descending aorta), and their tracheae exposed and cannulated using 0.58 mm-ID polyethylene tubing (Clay Adams, Parsippany, NJ) inserted through a slit below the larynx. The diaphragm was punctured and the lung infused (1.0 ml 3.7% paraformaldehyde in phosphate buffered saline; infusion pressure = 30 cm H2O). After infusion, the chest wall was opened, trachea ligated, heart, lung, and trachea removed en bloc and immersed in fixative (16 h; 4°C). At 24, 36, 48 h and at death, liver, kidney, and intestine were dissected and immediately placed into 10% buffered formalin (3.7% formaldehyde, pH = 7.4). Tissues were paraffin embedded, sectioned (5 µm), stained with hematoxylin and eosin, and examined by light microscopy. Additional analysis of the lung for nitrotyrosine deposition was performed on paraffin-embedded tissue sections as previously described (10). To assess pulmonary edema, lung wet-to-dry weight ratios were determined for unexposed mice and at death as described previously (4).

Statistical Analysis

The Mantel-Cox rank test was used for survival curve analysis and the t test statistic was used to compare mean survival times. For analysis of lung cytokine expression, serum nitrite, anti-nitrotyrosine stained cells, and lung wet-to-dry weight ratios, means were compared by two-way analysis of variance (ANOVA) followed by Student-Newman-Keuls method for multiple comparisons. When data was not normally distributed (failed the Kolmogorov-Smirnov test), log transformation was performed before ANOVA. Values are presented as means ± SEM. Significance was accepted for values of P < 0.05.

    Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Deletion of the Tyrosine Kinase Domain of Ron Increases Sensitivity to Nickel-Induced ALI

To directly test whether disruption of the Ron signaling pathway would increase sensitivity to nickel-induced ALI, Ron tk-/- and Ron tk+/+ mice were monitored for survival during continuous exposure to nickel. Survival time was decreased for Ron tk-/- mice compared with Ron tk+/+ mice (Figure 1). Although both Ron tk-/- and Ron tk+/+ mice succumbed to nickel-induced ALI, the mean survival time of Ron tk-/- mice preceded Ron tk+/+ mice by 16 h.


View larger version (18K):
[in this window]
[in a new window]
 
Figure 1.   Deletion of the tyrosine kinase domain of Ron in mice decreases survival time. Top panel: Mice with the targeted deletion of the tyrosine kinase domain of Ron (Ron tk-/-; n = 28) or controls (Ron tk+/+; n = 19) were continuously exposed to nickel and survival time monitored. The Ron tk-/- survival curve was significantly different than Ron tk+/+ (Mantel-Cox rank test, P < 0.05). Bottom panel: Mean survival time was significantly lower in Ron tk-/- mice. Values are means ± SEM (t test, *P < 0.05).

Early Pulmonary Cytokine Expression Is Greater in Ron tk-/- Mice

To explore whether loss of Ron signaling would disrupt regulation of cytokine expression in response to nickel-induced ALI, RNA levels of 13 inflammatory mediators were measured. Before exposure, baseline cytokine expression was not different between genotypes. At 12 h, IL-6, MCP-1, and MIP-2, expression in the lung of Ron tk-/- mice was greater than in Ron tk+/+ mice (Figure 2). By 24 h, IL-6 expression remained greater (4-fold) in Ron tk-/- mice compared with Ron tk+/+ mice, yet MCP-1 and MIP-2 expression was similar between genotypes. By 36 h, expression of IL-6, MCP-1, and MIP-2 was similar in Ron tk-/- and Ron tk+/+ mice, increasing (> 14-fold) over baseline (data not shown).


View larger version (12K):
[in this window]
[in a new window]
 
Figure 2.   Early cytokine expression is greater in mice deficient in the tyrosine kinase domain of Ron during nickel-induced ALI. Total lung RNA was isolated from mice lacking the tyrosine kinase domain of Ron (Ron tk-/-, closed circles) or controls (Ron tk+/+, open circles) after nickel exposure for 0, 12, or 24 h and analyzed by RNase protection assays. Expression of each cytokine was normalized to ribosomal L32 and is presented as fold of baseline (0 h) expression. Values are means ± SEM (n = 3). *Mean of Ron tk-/- greater than Ron tk+/+ mice, P < 0.05 by two-way ANOVA.

Of the other cytokines measured, a large (3- to 6-fold), early increase was noted in MIF expression (Table 1). However, MIF expression did not differ between Ron tk-/- and Ron tk+/+ mice. Ron tk-/- and Ron tk+/+ mice displayed a similar, late increase in IL-1beta , and with no significant change in TNF-alpha , TGF-alpha , IL-10, IL-12, iNOS, RANTES, or GM-CSF. Expression of IFN-gamma was undetectable (Table 1).

                              
View this table:
[in this window]
[in a new window]
 

TABLE 1
Pulmonary cytokine expression

Deletion of the Tyrosine Kinase Domain of Ron Augments Serum Nitrite Levels in Response to Nickel-Induced ALI

To assess whether deletion of the tyrosine kinase domain of Ron reduces inhibition of NO synthesis, serum nitrite was measured during nickel-induced ALI. Before exposure, baseline levels of serum nitrite were similar in Ron tk-/- and Ron tk+/+ mice. However, by 24 h, Ron tk-/- serum nitrite levels were ~ 2-fold those of Ron tk+/+ mice. Serum nitrite levels increased at 36 and 48 h in both genotypes with Ron tk-/- levels consistently remaining 2-fold more than Ron tk+/+ levels (Figure 3).


View larger version (16K):
[in this window]
[in a new window]
 
Figure 3.   Deletion of tyrosine kinase domain of Ron augments serum nitrite levels in response to nickel-induced ALI in mice. Serum was isolated from mice lacking the tyrosine kinase domain of Ron (Ron tk-/-, closed circles) and from their controls (Ron tk+/+, open circles) after nickel exposure for up to 48 h and analyzed for nitrite, a stable NO metabolite. Values are means ± SEM (n = 4). *Mean of Ron tk-/- greater than Ron tk+/+, two-way ANOVA, P < 0.05.

Pulmonary Tyrosine Nitration Is More Pronounced in Ron tk-/- Mice

To assess whether the increase in serum nitrite in Ron tk-/- mice corresponded to enhanced tyrosine nitration in the lung, the degree of nitrotyrosine deposition was evaluated by immunohistochemistry. After 24 h of nickel exposure, the number of antinitrotyrosine stained cells was greater in Ron tk-/- mice than in Ron tk+/+ mice (Figure 4; Table 2). Antinitrotyrosine staining was distributed throughout the lung, localizing primarily to type II cells. By 36 h, the number of antinitrotyrosine stained cells was similar between genotypes.


View larger version (29K):
[in this window]
[in a new window]
 
Figure 4.   Tyrosine nitration is more prominent at 24 h in mice deficient in the tyrosine kinase domain of Ron (Ron tk-/-) and occurs primarily in type II cells of the lung. By 24 h of exposure to nickel, Ron tk-/- mice display increased levels of tyrosine nitration compared with control (Ron tk+/+) mice (n = 2-4 mice/ genotype/time). By 36 h, tyrosine nitration is similar between genotypes. In the absence of nickel exposure, nitrotyrosine deposition was negligible and similar in both groups. Bar is 5 µm.

                              
View this table:
[in this window]
[in a new window]
 

TABLE 2
Pulmonary tyrosine nitration

Deletion of the Tyrosine Kinase Domain of Ron Hastens Development of Perivascular Edema

Ron tk-/- mice displayed an earlier onset of pulmonary pathology in response to nickel-induced ALI (Figure 5). By 36 h, perivascular edema had developed primarily in Ron tk-/- mice. At death, pulmonary pathology and pulmonary edema were similar in Ron tk-/- and Ron tk+/+ mice, indicated by histology and a lung wet-to-dry weight ratio that increased 1.5-fold in both genotypes (Figure 6).


View larger version (76K):
[in this window]
[in a new window]
 
Figure 5.   Deletion of Ron tyrosine kinase domain accelerates nickel-induced ALI. Following 36 h of nickel exposure, mice with a targeted deletion of the tyrosine kinase domain of Ron (Ron tk-/-) display more pronounced perivascular edema than control (Ron tk+/+) mice. At death, pulmonary pathology is similar in Ron tk-/- and Ron tk+/+ mice with development of perivascular edema in both genotypes. Bar is 100 µm.


View larger version (18K):
[in this window]
[in a new window]
 
Figure 6.   Pulmonary edema develops in response to nickel- induced ALI. Wet-to-dry lung weight ratios were determined at death for mice lacking the tyrosine kinase domain of Ron (Ron tk-/-) and for their controls (Ron tk+/+), following continuous exposure to nickel (n = 3/genotype, open bars). Unexposed mice were anesthetized and lung wet-to-dry weight ratios determined (n = 4/genotype, shaded bars). Values are means ± SEM. *Mean significantly increased with exposure in both Ron tk-/- and Ron tk+/+ mice; P < 0.05 by two-way ANOVA.

Kidney, liver, and intestine histology was also assessed. In the kidney, mild periglomerular cellular infiltration and focal tubular necrosis were apparent in experimental mice at death. In the liver, hepatocyte enlargement was observed in experimental mice at death. The kidney and hepatic pathologies were consistent with hypoxia, most likely resulting from the severe lung injury. Histology of the intestine was unremarkable.

    Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

These analyses indicate that deletion of tyrosine kinase activity of Ron augments the response to nickel-induced ALI. Ron tk-/- mice succumb earlier to nickel-induced ALI, express a larger, early increase in IL-6, MCP-1, and MIP-2, generate increased levels of nitrite, and display an earlier onset of pulmonary pathology and enhanced tyrosine nitrosylation. Thus, the tyrosine kinase domain of Ron regulates, in part, the response to nickel-induced ALI.

To examine the enhanced sensitivity of Ron tk-/- mice in response to nickel-induced ALI, pulmonary cytokine expression was evaluated. Early increases in the expression of IL-6, MCP-1, and MIP-2 were greater in Ron tk-/- mice than in Ron tk+/+ mice. Elevation of these cytokines is indicative of epithelial injury and macrophage activation during lung injury. In addition, these cytokines act in a paracrine fashion to activate resident macrophage and epithelial cells. This activation accelerates pathogenesis, in part, by augmenting the synthesis of reactive oxygen and nitrogen species and proteolytic enzymes.

IL-6 can act as an anti-inflammatory mediator (14), yet IL-6 knockout mice develop less NO formation in response to lung injury (15). The increase in IL-6 expression at 12 h may have contributed to the increased NO synthesis observed in the Ron tk-/- mice. In addition to IL-6, the increase in MCP-1 expression at 12 h in Ron tk-/- mice exceeded that of Ron tk+/+ mice. MCP-1 is a potent monocyte chemoattractant capable of stimulating monocyte respiratory burst and release of lysosomal enzymes (16). Along with IL-6 and MCP-1, the increase in MIP-2 was greater in Ron tk-/- mice at 12 hours. MIP-2 mediates neutrophilic infiltration (17) and contributes to the pathogenesis of inflammatory lung disease (18). In addition to the early increase in the expression of IL-6, MCP-1, and MIP-2, earlier (< 12 h) increases in other cytokines may have been missed because the first time assessed was at 12 h and these increases likewise could have contributed to the accelerated onset of pathogenesis and mortality.

Expression of IL-6, MCP-1, and MIP-2 was stimulated in the Ron tk-/- mice as early as 12 h. Evidence from our previous microarray analysis suggested that activation of resident alveolar macrophage and epithelial cells is an early response (3-8 h) to nickel-induced ALI (5). While Ron has been found to be expressed in airway epithelial cells (19), expression in resident alveolar macrophage is uncertain (20, 21). This suggests that epithelial expression of Ron may downregulate select pulmonary cytokine expression in response to ALI.

Recently, the cytokine MIF has emerged as a mediator in acute respiratory distress syndrome, a severe form of ALI (22). Recombinant MIF increases sepsis-induced mortality (23) and neutrophilic infiltration (24). Treatment with a neutralizing anti-MIF antibody is protective, resulting in decreased mortality and diminished neutrophilic infiltration. In response to nickel-induced ALI, MIF expression increased similarly in Ron tk-/- and Ron tk+/+ mice. Ron signaling may serve as a downstream inhibitor of MIF activity with loss of Ron signaling in Ron tk-/- mice accelerating pulmonary pathogenesis and mortality due to aberrant downstream regulation by this cytokine.

One function of Ron is to inhibit NO synthesis in peritoneal macrophages (10, 13, 25). Whereas the mechanism of this inhibition is not fully understood, PI-3 kinase activation and NF-kappa B inhibition have been shown to be important determinants (8, 26). Synthesis of nanomolar concentrations of NO is requisite for physiologic signal transduction, yet at micromolar concentrations, NO is damaging to tissue and is associated with mortality (9). Previously, several genes known to be altered by reactive oxygen species and the excess production of NO (e.g., glutathione-S-transferase, metallothionein, heme oxygenase) were found increased in response to nickel-induced ALI (5). When reactive oxygen species, such as superoxide, are abundant, they can react with excess NO to produce peroxynitrite (27). Peroxynitrite is capable of nitrating biologic molecules, including tyrosine residues, thiol groups, nucleic acids, and lipids, thereby impairing cellular function. In addition to elevated serum nitrite levels in Ron tk-/- mice, pulmonary tyrosine nitration exceeded that of Ron tk+/+ mice. Excess NO contributes to enhanced vascular permeability in response to ALI (28). Possibly the larger early increase in NO and enhanced tyrosine nitration in Ron tk-/- induced the earlier onset of perivascular edema and lethality in response to nickel-induced ALI.

In response to nickel-induced ALI, iNOS gene expression remained unchanged in either genotype. In macrophages, Ron signaling via PI-3 kinase decreases iNOS gene expression. However, when PI-3 kinase is blocked using wortmannin, NO levels are still attenuated, suggesting that Ron is capable of inhibiting NO synthesis separate from the inhibition of iNOS (8). Because macrophage also express constitutive NO synthases (29, 30), it is possible that the regulation of NO by Ron in response to nickel- induced ALI is through the modulation of NO synthesis by constitutive isoforms.

Notably, Ron tk-/- mice succumb to nickel-induced ALI earlier than any inbred strain previously examined (4). The sensitive mouse strain, A, succumbs to nickel-induced ALI hours earlier than the resistant C57BL/6 strain, and death in Ron tk-/- mice precedes that of A mice. At death, Ron tk-/-, A, and C57Bl/6, mice develop pulmonary edema (increased lung wet-to-dry weight ratio). Although unique factors such as genetic determinants, including those that regulate signaling pathways, may determine sensitivity, pulmonary edema is a consistent end stage response. The early increase in cytokine expression, large increase in NO, early onset of perivascular edema, pulmonary nitration, and death in Ron tk-/- mice suggests that Ron regulates critical responses to nickel-induced ALI.

In summary, our studies indicate that deletion of the tyrosine kinase domain of Ron increases sensitivity to nickel-induced ALI. Decreased survival time in Ron tk-/- mice, larger, early increases in IL-6, MCP-1, and MIP-2, augmented serum nitrite levels, earlier onset of pulmonary pathology, and enhanced tyrosine nitration indicate the critical role of Ron in regulation of the response to ALI and suggest targets for therapeutic intervention.

    Footnotes

Address correspondence to: Susan E. Waltz, Ph.D., Division of Developmental Biology, Children's Hospital Research Foundation, 3333 Burnet Avenue, Cincinnati, OH 45229. E-mail: swaltz{at}chmcc.org

(Received in original form May 3, 2001 and in revised form August 31, 2001).

Abbreviations: acute lung injury, ALI; granulocyte macrophage-colony stimulating factor, GM-CSF; hepatocyte growth factor-like protein/macrophage stimulating protein, HGFL/MSP; interferon-gamma , IFN-gamma ; interleukin, IL; inducible NO synthase, iNOS; monocyte chemotactic protein, MCP; macrophage migration inhibitory factor, MIF; macrophage inflammatory protein, MIP; nitric oxide, NO; phosphatidylinositol-3, PI-3; regulated upon activation, normal T cells expressed and secreted, RANTES; transforming growth factor, TGF; tumor necrosis factor, TNF.

Acknowledgments: This study was supported by the Marion Merrel Dow Foundation (S.E.W.), the March of Dimes Organization (S.E.W.), the American Heart Association (S.E.W.), a Board of Trustees grant from the Children's Hospital Research Foundation (S.E.W.), by grants HD-36888 (S.E.W.), DK-47003 (S.J.F.D.), DK-58182 (S.J.F.D.), ES10562 (G.D.L.), HL-65612 (G.D.L.), ES06096 (G.D.L.), HL-65613 (G.D.L.), from the National Institutes of Health, and by the Health Effects Institute (G.D.L.). The Health Effects Institute is an organization jointly funded by the US Environmental Protection Agency, Assistance Agreement X-812059, and automotive manufacturers. The contents of this article do not necessarily reflect the views of the Health Effects Institute or the policies of the US Environmental Protection Agency or automotive manufacturers. S.M. is a recipient of the US Environmental Protection Agency Science to Achieve Results Graduate Fellowship and the Albert J. Ryan Fellowship, and this work was conducted in partial fulfillment of the requirements for the Ph.D. degree at the University of Cincinnati.
    References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Pittet, J. F., R. C. Mackersie, T. R. Martin, and M. A. Matthay. 1997. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am. J. Respir. Crit. Care Med. 155: 1187-1205 [Medline].

2. Jobe, A. H., and M. Ikegami. 1998. Surfactant and acute lung injury. Proc. Assoc. Am. Physicians 110: 489-495 . [Medline]

3. Benson, J. M., I. Y. Chang, Y. S. Cheng, F. F. Hahn, C. H. Kennedy, E. B. Barr, K. R. Maples, and M. B. Snipes. 1995. Particle clearance and histopathology in lungs of F344/N rats and B6C3F1 mice inhaling nickel oxide or nickel sulfate. Fundam. Appl. Toxicol. 28: 232-244 [Medline].

4. Wesselkamper, S. C., D. R. Prows, P. Biswas, K. Willeke, E. Bingham, and G. D. Leikauf. 2000. Genetic susceptibility to irritant-induced acute lung injury in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 279: L575-L582 [Abstract/Free Full Text].

5. McDowell, S. A., K. Gammon, C. J. Bachurski, J. S. Wiest, J. E. Leikauf, D. R. Prows, and G. D. Leikauf. 2000. Differential gene expression in the initiation and progression of nickel-induced acute lung injury. Am. J. Respir. Cell Mol. Biol. 23: 466-474 [Abstract/Free Full Text].

6. Wang, M. H., A. Iwama, A. Skeel, T. Suda, and E. J. Leonard. 1995. The murine stk gene product, a transmembrane protein tyrosine kinase, is a receptor for macrophage-stimulating protein. Proc. Natl. Acad. Sci. USA 92: 3933-3937 [Abstract/Free Full Text].

7. Iwama, A., N. Yamaguchi, and T. Suda. 1996. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family. Embo J. 15: 5866-5875 [Medline].

8. Chen, Y. Q., J. H. Fisher, and M. H. Wang. 1998. Activation of the RON receptor tyrosine kinase inhibits inducible nitric oxide synthase (iNOS) expression by murine peritoneal exudate macrophages: phosphatidylinositol-3 kinase is required for RON-mediated inhibition of iNOS expression. J. Immunol. 161: 4950-4959 [Abstract/Free Full Text].

9. MacMicking, J. D., C. Nathan, G. Hom, N. Chartrain, D. S. Fletcher, M. Trumbauer, K. Stevens, Q. W. Xie, K. Sokol, and N. Hutchinson. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81: 641-650 [Medline].

10. Waltz, S. E., L. Eaton, K. Toney-Earley, K. A. Hess, B. E. Peace, J. R. Ihlendorf, M.-H. Wang, K. H. Kaestner, and S. J. F. Degen. 2001. Ron- mediated cytoplasmic signaling is dispensable for viability but is required to limit inflammatory responses. J. Clin. Invest. 108: 567-576 [Medline].

11. Waltz, S. E., C. L. Toms, S. A. McDowell, L. A. Clay, R. S. Muraoka, E. L. Air, W. Y. Sun, M. B. Thomas, and S. J. Degen. 1998. Characterization of the mouse Ron/Stk receptor tyrosine kinase gene. Oncogene 16: 27-42 [Medline].

12. Bachurski, C. J., G. S. Pryhuber, S. W. Glasser, S. E. Kelly, and J. A. Whitsett. 1995. Tumor necrosis factor-alpha inhibits surfactant protein C gene transcription. J. Biol. Chem. 270: 19402-19407 [Abstract/Free Full Text].

13. Muraoka, R. S., W. Y. Sun, M. C. Colbert, S. E. Waltz, D. P. Witte, J. L. Degen, S. J. Friezner, and Degen. 1999. The Ron/STK receptor tyrosine kinase is essential for peri-implantation development in the mouse. J. Clin. Invest. 103: 1277-1285 [Medline].

14. Meng, Z. H., K. Dyer, T. R. Billiar, and D. J. Tweardy. 2000. Distinct effects of systemic infusion of G-CSF vs. IL-6 on lung and liver inflammation and injury in hemorrhagic shock. Shock 14: 41-48 [Medline].

15. Cuzzocrea, S., L. Sautebin, G. De Sarro, G. Costantino, L. Rombola, E. Mazzon, A. Ialenti, A. De Sarro, G. Ciliberto, M. Di Rosa, A. P. Caputi, and C. Thiemermann. 1999. Role of IL-6 in the pleurisy and lung injury caused by carrageenan. J. Immunol. 163: 5094-5104 [Abstract/Free Full Text].

16. Rollins, B. J., A. Walz, and M. Baggiolini. 1991. Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 78: 1112-1116 [Abstract/Free Full Text].

17. Wolpe, S. D., B. Sherry, D. Juers, G. Davatelis, R. W. Yurt, and A. Cerami. 1989. Identification and characterization of macrophage inflammatory protein 2.  Proc. Natl. Acad. Sci. USA 86: 612-616 [Abstract/Free Full Text].

18. Driscoll, K. E., D. G. Hassenbein, J. Carter, J. Poynter, T. N. Asquith, R. A. Grant, J. Whitten, M. P. Purdon, and R. Takigiku. 1993. Macrophage inflammatory proteins 1 and 2: expression by rat alveolar macrophages, fibroblasts, and epithelial cells and in rat lung after mineral dust exposure. Am. J. Respir. Cell Mol. Biol. 8: 311-318 .

19. Sakamoto, O., A. Iwama, R. Amitani, T. Takehara, N. Yamaguchi, T. Yamamoto, K. Masuyama, T. Yamanaka, M. Ando, and T. Suda. 1997. Role of macrophage-stimulating protein and its receptor, RON tyrosine kinase, in ciliary motility. J. Clin. Invest. 99: 701-709 [Medline].

20. Iwama, A., M.-H. Wang, N. Yamaguchi, K. Okano, T. Sudo, F. Gervais, C. Morissette, E. J. Leonard, and T. Suda. 1995. Terminal differentiation of murine resident peritoneal macrophages is characterized by expression of the STK protein tyrosine kinase, a receptor for macrophage-stimulating protein. Blood 86: 3394-3403 [Abstract/Free Full Text].

21. Waltz, S. E., S. A. McDowell, R. S. Muraoka, E. L. Air, L. M. Flick, Y. Q. Chen, M. H. Wang, and S. J. Degen. 1997. Functional characterization of domains contained in hepatocyte growth factor-like protein. J. Biol. Chem. 272: 30526-30537 [Abstract/Free Full Text].

22. Donnelly, S. C., C. Haslett, P. T. Reid, I. S. Grant, W. A. Wallace, C. N. Metz, L. J. Bruce, and R. Bucala. 1997. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat. Med. 3: 320-323 [Medline].

23. Calandra, T., B. Echtenacher, D. L. Roy, J. Pugin, C. N. Metz, L. Hultner, D. Heumann, D. Mannel, R. Bucala, and M. P. Glauser. 2000. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat. Med. 6: 164-170 [Medline].

24. Bozza, M., A. R. Satoskar, G. Lin, B. Lu, A. A. Humbles, C. Gerard, and J. R. David. 1999. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J. Exp. Med. 189: 341-346 [Abstract/Free Full Text].

25. Wang, M. H., G. W. Cox, T. Yoshimura, L. A. Sheffler, A. Skeel, and E. J. Leonard. 1994. Macrophage-stimulating protein inhibits induction of nitric oxide production by endotoxin- or cytokine-stimulated mouse macrophages. J. Biol. Chem. 269: 14027-14031 [Abstract/Free Full Text].

26. Liu, Q. P., K. Fruit, J. Ward, and P. H. Correll. 1999. Negative regulation of macrophage activation in response to IFN-gamma and lipopolysaccharide by the STK/RON receptor tyrosine kinase. J. Immunol. 163: 6606-6613 [Abstract/Free Full Text].

27. Eiserich, J. P., R. P. Patel, and V. B. O'Donnell. 1998. Pathophysiology of nitric oxide and related species: free radical reactions and modification of biomolecules. Mol. Aspects Med. 19: 221-357 [Medline].

28. Matsuo, N.. 1999. The role of intrapulmonary nitric oxide generation in the development of adult respiratory distress syndrome. Surg. Today 29: 1068-1074 [Medline].

29. van Straaten, J. F., D. S. Postma, W. Coers, J. A. Noordhoek, H. F. Kauffman, and W. Timens. 1998. Macrophages in lung tissue from patients with pulmonary emphysema express both inducible and endothelial nitric oxide synthase. Mod. Pathol. 11: 648-655 [Medline].

30. Miles, P. R., L. Bowman, A. Rengasamy, and L. Huffman. 1998. Constitutive nitric oxide production by rat alveolar macrophages. Am. J. Physiol. Lung Cell Mol. Physiol. 274: L360-L368 [Abstract/Free Full Text].





This article has been cited by other articles:


Home page
Toxicol SciHome page
M. Mongan, Z. Tan, L. Chen, Z. Peng, M. Dietsch, B. Su, G. Leikauf, and Y. Xia
Mitogen-activated Protein Kinase Kinase Kinase 1 Protects against Nickel-induced Acute Lung Injury
Toxicol. Sci., August 1, 2008; 104(2): 405 - 411.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. C. Wetzel, M. A. Leonis, A. Dent, M. A. Olson, A. M. Longmeier, P. A. Ney, G. P. Boivin, S. A. Kader, C. C. Caldwell, S. J. F. Degen, et al.
Short-form Ron receptor is required for normal IFN-{gamma} production in concanavalin A-induced acute liver injury
Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G253 - G261.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
A. Mallakin, L. W. Kutcher, S. A. McDowell, S. Kong, R. Schuster, A. B. Lentsch, B. J. Aronow, G. D. Leikauf, and S. E. Waltz
Gene Expression Profiles of Mst1r-Deficient Mice during Nickel-Induced Acute Lung Injury
Am. J. Respir. Cell Mol. Biol., January 1, 2006; 34(1): 15 - 27.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. E. Peace, K. Toney-Earley, M. H. Collins, and S. E. Waltz
Ron Receptor Signaling Augments Mammary Tumor Formation and Metastasis in a Murine Model of Breast Cancer
Cancer Res., February 15, 2005; 65(4): 1285 - 1293.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
P. H. Correll, A. C. Morrison, and M. A. Lutz
Receptor tyrosine kinases and the regulation of macrophage activation
J. Leukoc. Biol., May 1, 2004; 75(5): 731 - 737.
[Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. A. McDowell, K. Gammon, B. Zingarelli, C. J. Bachurski, B. J. Aronow, D. R. Prows, and G. D. Leikauf
Inhibition of Nitric Oxide Restores Surfactant Gene Expression following Nickel-Induced Acute Lung Injury
Am. J. Respir. Cell Mol. Biol., February 1, 2003; 28(2): 188 - 198.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McDowell, S. A.
Right arrow Articles by Waltz, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McDowell, S. A.
Right arrow Articles by Waltz, S. E.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2002 American Thoracic Society.